LAVA Therapeutics N.V. (LVTX)
NASDAQ: LVTX · Real-Time Price · USD
1.600
+0.100 (6.67%)
Nov 22, 2024, 4:00 PM EST - Market closed
LAVA Therapeutics Market Cap
LAVA Therapeutics has a market cap or net worth of $42.08 million as of November 22, 2024. Its market cap has increased by 33.38% in one year.
Market Cap
42.08M
Enterprise Value
-38.56M
1-Year Change
33.38%
Ranking
Category
Stock Price
$1.60
Market Cap Chart
Since the IPO on March 25, 2021, LAVA Therapeutics's market cap has decreased from $380.28M to $42.08M, a decrease of -88.94%. That is a compound annual growth rate of -45.20%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Nov 20, 2024 | 39.97M | -3.77% |
| Dec 29, 2023 | 41.54M | -54.86% |
| Dec 30, 2022 | 92.01M | -35.10% |
| Dec 31, 2021 | 141.77M | -62.72% |
| Mar 25, 2021 | 380.28M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Gain Therapeutics | 43.92M |
| Achilles Therapeutics | 43.57M |
| DIH Holding US | 43.38M |
| Omega Therapeutics | 43.35M |
| Rallybio | 42.32M |
| Calidi Biotherapeutics | 41.34M |
| NeueHealth | 41.27M |
| Iterum Therapeutics | 41.10M |